Hide filtersShow filters × Close Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option. Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc Bryan, Garnier & Co advises Astorg Partners on acquisition of Majority Stake in Metrologic Group, alongside Management and Founder Acquisition of Advania Bryan, Garnier & Co advises mc²i Groupe on its capital reorganization around its top management team, key managers and Indigo Capital Bryan, Garnier & Co advises the secondary private placement of 16% of CAST share capital Bryan, Garnier & Co advised Sculpteo, a pioneering champion in on-line 3d printing, in its Private Placement Bryan, Garnier & Co acts as Placement Agent for Nicox €27m Private Placement (PIPE) Equity Issue KomplettBank ASA Bryan, Garnier & Co acts as Placement Agent for Cardio3 BioScience’s €32m Capital Raise Bryan, Garnier & Co acts as Sole Placement Agent for Jahia’s €25m Growth Financing Round Bryan, Garnier & Co. GmbH advised OnePhone Germany on its Sale to Voiceworks
